Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix
- Details
- Category: Abbott

Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients
- Details
- Category: Boehringer Ingelheim

Genzyme's Alemtuzumab for Treatment of Multiple Sclerosis Granted Fast Track Status by FDA
- Details
- Category: Genzyme

Bristol-Myers Squibb Signs Agreements with ICON and PAREXEL
- Details
- Category: Bristol-Myers Squibb

Trial of Nexavar® in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint
- Details
- Category: Bayer

FDA advisory committee recommends approval of Novartis investigational treatment FTY720
- Details
- Category: Novartis

GSK drives Latin America growth strategy with acquisition of Laboratorios Phoenix
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- AVERROES Study Closes Early Due to Clear Evidence of Efficacy
- Ranbaxy Launches Antiplatelet Agent Prasugrel in India
- Americans Are Not Taking Action to Protect Themselves Against Muscle Loss
- Sanofi Pasteur Partners with Vivalis for the Discovery of Human Monoclonal Antibodies
- Merck Resubmits U.S. Application for Cladribine Tablets
- Phase III study showed Avastin-based regimen helped women with advanced ovarian cancer
- Phase 3 Study Showed MACUGEN® Improved Vision Over Standard of Care